Article

Ethnicity May Influence Risk of JCV in Patients With MS

Neurology Reviews. 2012 December;20(12):10,11
Author and Disclosure Information

 

References


—Erik Greb

Pages

Recommended Reading

FDA Approves Oral MS Drug Teriflunomide
MDedge Neurology
Ahead of the Journals: DEFINE and CONFIRM Support Oral BG-12’s Efficacy in Multiple Sclerosis
MDedge Neurology
Anthony Reder, MD, Discusses a 21-Year Follow-Up Study of Patients Who Have Multiple Sclerosis
MDedge Neurology
John DeLuca, PhD, Discusses the Assessment and Rehabilitation of Cognitive Impairment in Multiple Sclerosis
MDedge Neurology
New and Noteworthy Information—September
MDedge Neurology
New and Noteworthy Information—October
MDedge Neurology
BG-12 May Reduce Relapse Rate for Patients With MS
MDedge Neurology
News Briefs From the 28th Congress of ECTRIMS
MDedge Neurology
Physicians, Patients Differ in Weighing Benefits Versus Side Effects of MS Therapies
MDedge Neurology
Assisted Reproduction Treatment May Increase MS Disease Activity
MDedge Neurology